MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1200/jco.2011.37.0189

Медицинская библиотека · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Koppelmans Vincent, Breteler Monique M B, Boogerd Willem, Seynaeve Caroline, Gundy Chad, Schagen Sanne B

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

PURPOSE: Adjuvant chemotherapy for breast cancer can have adverse effects on cognition shortly after administration. Whether chemotherapy has any long-term effects on cognition is largely unknown, yet it becomes increasingly relevant because of the widespread use of chemotherapy for early-stage breast cancer and the improved survival. We investigated whether cyclophosphamide, methotrexate, and fluorouracil (CMF) chemotherapy for breast cancer is associated with worse cognitive performance more than 20 years after treatment.

PATIENTS AND

METHODS

This case-cohort study compared the cognitive performance of patients with breast cancer who had a history of adjuvant CMF chemotherapy treatment (six cycles; average time since treatment, 21 years; n = 196) to that of a population-based sample of women never diagnosed with cancer (n = 1,509). Participants were between 50 and 80 years of age. Exclusion criteria were ever use of adjuvant endocrine therapy, secondary malignancy, recurrence, and/or metastasis.

RESULTS

The women exposed to chemotherapy performed significantly worse than the reference group on cognitive tests of immediate (P = .015) and delayed verbal memory (P = .002), processing speed (P < .001), executive functioning (P = .013), and psychomotor speed (P = .001). They experienced fewer symptoms of depression (P < .001), yet had significantly more memory complaints on two of three measures that could not be explained by cognitive test performance.

CONCLUSION

Survivors of breast cancer treated with adjuvant CMF chemotherapy more than 20 years ago perform worse, on average, than random population controls on neuropsychological tests. The pattern of cognitive problems is largely similar to that observed in patients shortly after cessation of chemotherapy. This study suggests that cognitive deficits following breast cancer diagnosis and subsequent CMF chemotherapy can be long lasting.

Для цитирования: Koppelmans Vincent, Breteler Monique M B, Boogerd Willem, Seynaeve Caroline, Gundy Chad, Schagen Sanne B. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012. DOI: 10.1200/jco.2011.37.0189.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.